Valneva Withdraws U.S. Applications for Chikungunya Vaccine Approval
On January 19, 2024, French vaccine manufacturer Valneva announced that it is voluntarily withdrawing its applications for both formal and investigational approval of its chikungunya vaccine in the United States.…